Tech Company Financing Transactions
ThruFlo Endovascular Funding Round
Atlas MedInnovation and private investors participated in a Seed venture round for ThruFlo Endovascular. The funding round was recorded on 6/11/2026.
Transaction Overview
Company Name
Announced On
6/11/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Atlas MedInnovation (Lead Investor)
Proceeds Purpose
The company intends to use the funds to establish formal R&D operations, complete device design, initiate additional pre-clinical studies, and submit an investigational device exemption (IDE) application to the FDA.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
470 Wald
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Undisclosed
Website
Email Address
Overview
ThruFlo Endovascular is a clinical-stage medical device company focused on endovascular solutions for life-threatening neurovascular conditions. We are headquartered in Southern California and supported by a world-class team of engineers, clinicians, and advisors. Mission: To develop and commercialize next-generation flow diversion technology that expands the addressable patient population and improves outcomes for those at risk of life-threatening aneurysm rupture.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samuel Shaolian
Chief Medical Officer
George Teitelbaum
Browse more venture capital transactions:
Prev: 6/11/2026: Satispay venture capital transaction
Next: 6/11/2026: Dapple AI Networks venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs